STERIS plc $STE Stake Increased by Mufg Securities Americas Inc.

Mufg Securities Americas Inc. lifted its holdings in STERIS plc (NYSE:STE) by 25.2% in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,177 shares of the medical equipment provider’s stock after buying an additional 438 shares during the period. Mufg Securities Americas Inc.’s holdings in STERIS were worth $523,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the business. Allworth Financial LP boosted its position in STERIS by 7.3% during the 2nd quarter. Allworth Financial LP now owns 661 shares of the medical equipment provider’s stock worth $159,000 after acquiring an additional 45 shares during the period. Ashton Thomas Private Wealth LLC lifted its position in shares of STERIS by 3.5% in the first quarter. Ashton Thomas Private Wealth LLC now owns 1,611 shares of the medical equipment provider’s stock worth $365,000 after purchasing an additional 54 shares in the last quarter. Cetera Investment Advisers lifted its position in shares of STERIS by 0.9% in the first quarter. Cetera Investment Advisers now owns 6,999 shares of the medical equipment provider’s stock worth $1,586,000 after purchasing an additional 63 shares in the last quarter. Horizon Investments LLC boosted its holdings in shares of STERIS by 4.7% during the first quarter. Horizon Investments LLC now owns 1,410 shares of the medical equipment provider’s stock worth $320,000 after purchasing an additional 63 shares during the period. Finally, Alliance Wealth Advisors LLC UT increased its stake in STERIS by 2.0% in the 1st quarter. Alliance Wealth Advisors LLC UT now owns 3,305 shares of the medical equipment provider’s stock valued at $749,000 after buying an additional 64 shares during the period. 94.69% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, VP Renato Tamaro sold 5,036 shares of the firm’s stock in a transaction on Tuesday, November 18th. The shares were sold at an average price of $257.55, for a total value of $1,297,021.80. Following the transaction, the vice president directly owned 5,695 shares in the company, valued at approximately $1,466,747.25. This trade represents a 46.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, VP John Adam Zangerle sold 15,000 shares of the company’s stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $265.14, for a total transaction of $3,977,100.00. Following the sale, the vice president owned 33,669 shares of the company’s stock, valued at $8,926,998.66. This trade represents a 30.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 20,195 shares of company stock valued at $5,312,571 over the last 90 days. 1.07% of the stock is currently owned by company insiders.

STERIS Trading Down 0.0%

STERIS stock opened at $263.27 on Tuesday. STERIS plc has a one year low of $200.98 and a one year high of $268.30. The company’s fifty day moving average price is $247.21 and its two-hundred day moving average price is $241.92. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.22 and a quick ratio of 1.53. The company has a market capitalization of $25.84 billion, a price-to-earnings ratio of 40.32 and a beta of 1.02.

STERIS (NYSE:STE) last released its quarterly earnings results on Wednesday, November 5th. The medical equipment provider reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.38 by $0.09. The company had revenue of $1.46 billion during the quarter, compared to the consensus estimate of $1.43 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.During the same quarter in the prior year, the company posted $2.14 EPS. STERIS has set its FY 2026 guidance at 10.150-10.30 EPS. On average, analysts forecast that STERIS plc will post 9.08 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be issued a dividend of $0.63 per share. This represents a $2.52 annualized dividend and a yield of 1.0%. The ex-dividend date is Tuesday, November 18th. STERIS’s dividend payout ratio (DPR) is 36.21%.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on the stock. Wall Street Zen raised shares of STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Weiss Ratings reissued a “buy (b)” rating on shares of STERIS in a research report on Tuesday, October 14th. Finally, Morgan Stanley upped their target price on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research report on Friday, August 8th. Seven analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $273.50.

About STERIS

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.